These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36018221)

  • 21. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
    Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
    Br J Dermatol; 2021 Jul; 185(1):139-146. PubMed ID: 33393074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial.
    Chalmers JR; Haines RH; Mitchell EJ; Thomas KS; Brown SJ; Ridd M; Lawton S; Simpson EL; Cork MJ; Sach TH; Bradshaw LE; Montgomery AA; Boyle RJ; Williams HC
    Trials; 2017 Jul; 18(1):343. PubMed ID: 28732519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
    van Geel N; Hamzavi IH; Pandya AG; Wolkerstorfer A; Seneschal J; Garg A; Spuls P; Terwee CB; Mallett S; Speeckaert R; Meurant JM; Eleftheriadou V; Ezzedine K
    Trials; 2022 Jul; 23(1):591. PubMed ID: 35871019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hand eczema registries: Background, value and future prospects : Registry data in hand eczema research].
    Ofenloch R; Apfelbacher C; Weisshaar E
    Hautarzt; 2018 Oct; 69(10):809-814. PubMed ID: 30135968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common data items in seven European oesophagogastric cancer surgery registries: towards a European upper GI cancer audit (EURECCA Upper GI).
    de Steur WO; Henneman D; Allum WH; Dikken JL; van Sandick JW; Reynolds J; Mariette C; Jensen L; Johansson J; Kolodziejczyk P; Hardwick RH; van de Velde CJ;
    Eur J Surg Oncol; 2014 Mar; 40(3):325-9. PubMed ID: 24412054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.
    Gerbens LA; Prinsen CA; Chalmers JR; Drucker AM; von Kobyletzki LB; Limpens J; Nankervis H; Svensson Å; Terwee CB; Zhang J; Apfelbacher CJ; Spuls PI;
    Allergy; 2017 Jan; 72(1):146-163. PubMed ID: 27322918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.
    Kamphuis E; Loman L; Han HL; Romeijn GLE; Politiek K; Schuttelaar MLA
    Contact Dermatitis; 2023 May; 88(5):351-362. PubMed ID: 36621910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany.
    Abraham S; Haufe E; Harder I; Heratizadeh A; Kleinheinz A; Wollenberg A; Weisshaar E; Augustin M; Wiemers F; Zink A; Biedermann T; von Kiedrowski R; Hilgers M; Worm M; Pawlak M; Sticherling M; Fell I; Handrick C; Schäkel K; Staubach P; Asmussen A; Schwarz B; Bell M; Neubert K; Effendy I; Bieber T; Homey B; Gerlach B; Tchitcherina E; Stahl M; Schwichtenberg U; Rossbacher J; Buck P; Mempel M; Beissert S; Werfel T; Weidinger S; Schmitt J;
    Br J Dermatol; 2020 Aug; 183(2):382-384. PubMed ID: 32068242
    [No Abstract]   [Full Text] [Related]  

  • 30. Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry.
    Pilz AC; Schielein MC; Schuster B; Heinrich L; Haufe E; Abraham S; Heratizadeh A; Harder I; Kleinheinz A; Wollenberg A; Wiemers F; Weisshaar E; Augustin M; von Kiedrowski R; Pawlak M; Schäkel K; Wildberger J; Hilgers M; Werfel T; Weidinger S; Schmitt J; Biedermann T; Zink A;
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):413-421. PubMed ID: 34743344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults.
    Ring J; Zink A; Arents BWM; Seitz IA; Mensing U; Schielein MC; Wettemann N; de Carlo G; Fink-Wagner A
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1331-1340. PubMed ID: 31002197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hand eczema, atopic dermatitis and filaggrin mutations in adult Danes: a registry-based study assessing risk of disability pension.
    Heede NG; Thuesen BH; Thyssen JP; Linneberg A; Szecsi PB; Stender S; Menné T; Johansen JD
    Contact Dermatitis; 2017 Aug; 77(2):95-105. PubMed ID: 28425595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HOME Core outcome set for clinical trials of atopic dermatitis.
    Williams HC; Schmitt J; Thomas KS; Spuls PI; Simpson EL; Apfelbacher CJ; Chalmers JR; Furue M; Katoh N; Gerbens LAA; Leshem YA; Howells L; Singh JA; Boers M;
    J Allergy Clin Immunol; 2022 Jun; 149(6):1899-1911. PubMed ID: 35351441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Content validity of the Recap of atopic eczema (RECAP) instrument in Dutch, English and German to measure eczema control in young people with atopic eczema: a cognitive interview study.
    Gabes M; Ragamin A; Baker A; Kann G; Donhauser T; Gabes D; Howells L; Thomas KS; Oosterhaven JAF; Pasmans SGMA; Schuttelaar ML; Apfelbacher C
    Br J Dermatol; 2022 Dec; 187(6):919-926. PubMed ID: 35842231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.
    Schmitt J; Spuls PI; Thomas KS; Simpson E; Furue M; Deckert S; Dohil M; Apfelbacher C; Singh JA; Chalmers J; Williams HC;
    J Allergy Clin Immunol; 2014 Oct; 134(4):800-7. PubMed ID: 25282560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Status report on the atopic dermatitis registry TREATgermany.
    Siegels D; Haufe E; Heinrich L; Werfel T; Weidinger S; Schmitt J;
    Allergol Select; 2021; 5():274-286. PubMed ID: 34532636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review.
    Sach TH; McManus E; Mcmonagle C; Levell N
    Syst Rev; 2016 May; 5():90. PubMed ID: 27230780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological and educational interventions for atopic eczema in children.
    Ersser SJ; Cowdell F; Latter S; Gardiner E; Flohr C; Thompson AR; Jackson K; Farasat H; Ware F; Drury A
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD004054. PubMed ID: 24399641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project.
    de Leede EM; Sibinga Mulder BG; Bastiaannet E; Poston GJ; Sahora K; Van Eycken E; Valerianova Z; Mortensen MB; Dralle H; Primic-Žakelj M; Borràs JM; Gasslander T; Ryzhov A; Lemmens VE; Mieog JS; Boelens PG; van de Velde CJ; Bonsing BA
    Eur J Surg Oncol; 2016 Sep; 42(9):1414-9. PubMed ID: 27061790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczema.
    Howells L; Thomas KS; Sears AV; Nasr I; Wollenberg A; Schuttelaar MLA; Romeijn GLE; Paller AS; Mueller K; Doytcheva K; Kataoka Y; Daguze J; Barbarot S; von Kobyletzki LB; Beckman L; Ratib S; Cowdell F; Santer M; Chalmers JR;
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1124-1132. PubMed ID: 30720903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.